Medtronic Inc. (MDT): Today's Featured Health Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Medtronic ( MDT) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 0.3%. By the end of trading, Medtronic rose $1.13 (2.1%) to $54.73 on heavy volume. Throughout the day, 9,432,700 shares of Medtronic exchanged hands as compared to its average daily volume of 4,446,000 shares. The stock ranged in a price between $53.73-$54.96 after having opened the day at $53.92 as compared to the previous trading day's close of $53.60. Other companies within the Health Services industry that increased today were: Medical Action Industries ( MDCI), up 22.8%, Covance ( CVD), up 5.5%, Centene Corporation ( CNC), up 5.4% and Foundation Medicine ( FMI), up 4.8%.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company operates in two segments, Cardiac and Vascular Group, and Restorative Therapies Group. Medtronic has a market cap of $54.6 billion and is part of the health care sector. Shares are down 6.6% year to date as of the close of trading on Tuesday. Currently there are 7 analysts that rate Medtronic a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, increase in net income and notable return on equity. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

On the negative front, Genomic Health ( GHDX), down 8.9%, BioTelemetry ( BEAT), down 8.6%, Uroplasty ( UPI), down 6.6% and Spherix ( SPEX), down 5.9% , were all laggards within the health services industry with Align Technology ( ALGN) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

3 Large-Cap Healthcare Stocks You Must Buy Following the Market Pullback

3 Large-Cap Healthcare Stocks You Must Buy Following the Market Pullback

The 5 Best Dividend Aristocrats For 2018

The 5 Best Dividend Aristocrats For 2018

Changes to Federal Tax Law Just What the Doctor Ordered for Healthcare Firms

Changes to Federal Tax Law Just What the Doctor Ordered for Healthcare Firms

These Stocks Are Showing Reversal Patterns

These Stocks Are Showing Reversal Patterns